Skip to content
Search

Latest Stories

PDA calls for 'tripartite structures' for community pharmacists' pay negotiations in Wales

The Pharmacists' Defence Association (PDA) has reacted to the chief pharmaceutical officer (CPhO) for Wales’s offer for community pharmacy contractors, offering a funding uplift for community pharmacy on the condition of an increase in pay for some staff by at least the amount currently being imposed upon NHS employees.

The PDA has expressed a mixed reaction to the intervention being attempted by the Welsh government.


“It is unusual for a government to be so closely involved in the pay of their suppliers’ employees and those at some community pharmacy employers have a contractual right to a pay review at times of year that may not synchronize with the government’s financial cycle, so this initiative may have different impacts at different employers,” said the association.

“In addition, the PDA negotiates pay at the largest two community pharmacy employers and works alongside other trade unions that organise other pharmacy workers. This government intervention must not disrupt or attempt to bypass those processes.”

PDA director Paul Day said: “Every client for any product or service has a responsibility for conditions along their supply chain, and in general we endorse the concept of conditions being applied to suppliers that aim to improve workers’ conditions and patient care. For example, we believe that it would not only be reasonable for a Welsh Labour government to require all suppliers to be a living wage employer and to recognise a trade union, but the government could also add requirements on operational standards such as safe staffing levels. However, the context and consequences of this specific intervention also need to be considered.”

Unlike the power of recognised trade unions to collectively bargain for permanent contractual improvements, which can include higher pay for all workers, the intervention by the CPhO for Wales, Andrew Evans, gives contractors the choice to increase pay or to receive a lower increase in funding.

While helpful in some instances, unlike trade union negotiations it does not restrict those employers from unilaterally deciding to try and reduce other aspects of reward in consequence. This highlights why the better solution would be for the government in Wales to work effectively in social partnership with trade unions and employers, and make it easier for unions in Community Pharmacy to collectively bargain on behalf of their members.

The association informed government in Wales that the NHS pay award has been rejected by a majority of PDA members employed by the NHS and is likely to also to be rejected by the health professionals and other NHS employees represented by other trade unions. The pay proposal, which is being presented by government as a 4 per cent increase, actually provides pharmacists at some grades with as little as a 1.3 per cent increase. Several health unions are actively preparing for industrial action ballots relating to this issue

Paul Day continued: “While incentivising private community pharmacy contractors to increase pay by no worse than the government’s plans for their own employees is better than accepting that they may otherwise do worse than the NHS, this could also be seen as sending a message to those NHS employed pharmacists, who are also represented by the PDA, that the Welsh government is not listening to their response to the NHS pay proposal.

"Some community pharmacy employers are part of large profit making multi-national corporations, who may have already decided to give this level of pay increase due to the pressures of recruitment and retention. In such scenarios the Welsh government are reimbursing that spending and this will prop up profit margins at those employers and not have any impact on pay rates. That the government would rather do that than redirect that same money towards improving the pay of their own NHS employees is also a choice by the Minister which some pharmacists may question.”

The PDA reiterates its call for Eluned Morgan, the minister for health and social services in the Welsh government, to exercise leadership on the sectoral relationships. The PDA wants the Minister to instigate tripartite structures as part of a social partnership agreement to bring together the government, employers, and independent trade unions from the sector on an ongoing basis. Such structures could then properly discuss and progress issues and opportunities relating to pay & conditions, health and safety, patient safety and more.

More For You

Prostate cancer: At-home saliva test could save NHS £500 million annually

PRS saliva test can identify prostate cancer that was missed by an MRI scan

Photo credit: gettyimages

Prostate cancer: Spit test better than blood test in spotting men at highest risk

A simple at-home spit test could help detect prostate cancer earlier, saving the NHS around £500 million a year, according to new research published in the New England Journal of Medicine.

Funded by the National Institute for Health and Care Research (NIHR), the study found that the DNA-based saliva test was more accurate than the current prostate-specific antigen (PSA) blood test in identifying men at risk of developing prostate cancer.

Keep ReadingShow less
RPS launches innovative new learning resources for members

With RPS Learn, pharmacists can develop a new skill or improve their understanding of practice or a clinical topic.

Gettyimages

RPS launches new learning resources to boost career development for members

The Royal Pharmaceutical Society (RPS) has launched a new online learning platform designed to support the practice, development and career advancement of its members.

The new platform, called RPS Learn, offers a diverse range of bite-size learning content, available on-demand, catering to all levels — from introductory to advanced and specialist —combining new content with RPS's renowned expertise in education and training to achieve excellence for learners.

Keep ReadingShow less
NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
AAH upgrades ordering portal, making procurement easier for pharmacies

AAH Cascade compares prices and availability across suppliers

AAH Warehouse

AAH upgrades ordering portal to improve product visibility

Leading pharmaceutical wholesaler AAH Pharmaceuticals Ltd has introduced new digital functionalities to AAH Cascade, its independently managed ordering portal, making procurement easier and more cost-effective for pharmacies.

AAH Cascade compares product prices and availability across multiple suppliers, eliminating the need for manual searches.

Keep ReadingShow less